Supply of Amlodipine Besylate 10 mg Tablets (90-count bottles)

The contract obligates the supplier to manufacture and deliver generic Amlodipine Besylate 10 mg tablets in 90-count bottles with child-resistant packaging that complies with all FDA regulations and federal procurement standards. The product must meet stringent quality, safety, and labeling requirements to ensure suitability for federal use, particularly within the Department of Defense’s healthcare supply chain. The packaging format and dosage strength are specifically defined, and adherence to these specifications is mandatory for award consideration. The contract is classified as a subcontract under NAICS code 325412, indicating pharmaceutical manufacturing, and is issued by DLA Troop Support, a division of the Department of Defense. The opportunity was posted on July 13, 2026, with a firm response deadline of August 13, 2026, at 7:00 p.m. Eastern Time. While no set-aside provisions or specific small business preferences are indicated, the place of performance and point of contact details are not provided, suggesting the supplier may be required to deliver to federal distribution nodes or designated military medical facilities without geographic restriction. All bids must demonstrate full compliance with federal pharmaceutical procurement protocols and packaging regulations.